Amgen Stock Hits New High Following Strong Q2 Earnings

Amgen Inc.'s (ISIN US0311621009) stock continued its upward trend, closing at $415.21 on August 17, 2026, after a strong second quarter and higher full-year earnings outlook.

The company's Q2 2026 results exceeded forecasts, with revenue of $10.1 billion representing a 10 percent year-over-year increase.

GAAP earnings per share rose 65 percent to $4.37 in Q2 2026, while non-GAAP EPS increased 4 percent to $6.29 compared to the prior-year quarter.

The company's cash generation also improved, with free cash flow of $3.5 billion in Q2 2026, up from $1.9 billion in the same quarter of the prior year.